Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Ferrara

Showing results (41-50 of 313) with videos related to

Pageof 32
Sort By:
Medical Hypotheses|January 18, 2021
Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19Antonio Vitiello, Raffaele La Porta, Francesco Ferrara
SN Comprehensive Clinical Medicine|August 25, 2020
The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care UnitFrancesco Ferrara, Francesco De Rosa, Antonio Vitiello
BMJ Evidence-Based Medicine|July 29, 2020
Sacubitril, valsartan and SARS-CoV-2Antonio Vitiello, Raffaele La Porta, Francesco Ferrara
SN Comprehensive Clinical Medicine|August 25, 2020
Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?Francesco Ferrara, Francesco De Rosa, Antonio Vitiello
Irish Journal of Medical Science|January 12, 2021
Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?Antonio Vitiello, Francesco Ferrara, Raffaele La Porta
International Journal of Dermatology|June 14, 2025
The Problem of Antimicrobial Resistance in Scabies: An Emerging Public Health ThreatAndrea Zovi, Francesco Ferrara, Roberto Langella, et al.
Heart Failure Clinics|March 6, 2019
Right Ventricular Size and Function in Chronic Heart Failure: Not to Be ForgottenXiao Zhou, Francesco Ferrara, Carla Contaldi, et al.
Herz|November 4, 2022
Overview of pharmacotherapy targeting COVID-19 disease based on ACE-2: current challenges and future directionsAntonio Vitiello, Andrea Zovi, Ugo Trama, et al.
Pharmaceutical Research|March 5, 2024
Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory FrameworkAlessia Romagnoli, Francesco Ferrara, Roberto Langella, et al.
Cancers|October 27, 2022
Precision Medicine in the Treatment of Locally Advanced or Metastatic Urothelial Cancer: New Molecular Targets and Pharmacological TherapiesAntonio Vitiello, Francesco Ferrara, Ruggero Lasala, et al.
Pageof 32

Showing results (41-50 of 313) with videos related to

Sort By:
Pageof 32
Medical Hypotheses|January 18, 2021
Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19Antonio Vitiello, Raffaele La Porta, Francesco Ferrara
SN Comprehensive Clinical Medicine|August 25, 2020
The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care UnitFrancesco Ferrara, Francesco De Rosa, Antonio Vitiello
BMJ Evidence-Based Medicine|July 29, 2020
Sacubitril, valsartan and SARS-CoV-2Antonio Vitiello, Raffaele La Porta, Francesco Ferrara
SN Comprehensive Clinical Medicine|August 25, 2020
Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?Francesco Ferrara, Francesco De Rosa, Antonio Vitiello
Irish Journal of Medical Science|January 12, 2021
Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?Antonio Vitiello, Francesco Ferrara, Raffaele La Porta
International Journal of Dermatology|June 14, 2025
The Problem of Antimicrobial Resistance in Scabies: An Emerging Public Health ThreatAndrea Zovi, Francesco Ferrara, Roberto Langella, et al.
Heart Failure Clinics|March 6, 2019
Right Ventricular Size and Function in Chronic Heart Failure: Not to Be ForgottenXiao Zhou, Francesco Ferrara, Carla Contaldi, et al.
Herz|November 4, 2022
Overview of pharmacotherapy targeting COVID-19 disease based on ACE-2: current challenges and future directionsAntonio Vitiello, Andrea Zovi, Ugo Trama, et al.
Pharmaceutical Research|March 5, 2024
Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory FrameworkAlessia Romagnoli, Francesco Ferrara, Roberto Langella, et al.
Cancers|October 27, 2022
Precision Medicine in the Treatment of Locally Advanced or Metastatic Urothelial Cancer: New Molecular Targets and Pharmacological TherapiesAntonio Vitiello, Francesco Ferrara, Ruggero Lasala, et al.
Pageof 32